Joshua Berlin, MD
Enriched profileOwner, Joshua M. Berlin MD Dermatology · Premier Dermatology Partners
Joshua Berlin is Owner, Joshua M. Berlin MD Dermatology at Premier Dermatology Partners. OpenAlex indexes 28 publications with 450 citations (h-index 10); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.
Data verified 4 Nov 2026
Overview
Updated 4 Nov 2026
Joshua Berlin, MD, is Owner, Joshua M. Berlin MD Dermatology at Premier Dermatology Partners. The public record shows 28 publications with 450 citations (h-index 10), centered on Acne / Hidradenitis, Acne Vulgaris. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 23 companies.
- Top research focus: Acne / Hidradenitis
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 23 companies
Generated from the cited public record · current as of 4 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 4 Nov 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- A Novel Combination Oral Agent to Treat Acne Vulgaris
Sponsor: Nexgen Dermatologics, Inc.
- A Novel Oral Natural Extract for the Treatment of Senile Purpura
Sponsor: Nexgen Dermatologics, Inc.
Industry payments
Updated 4 Nov 2026
23 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20257 payments
- Arcutis Biotherapeutics, Inc.Program year20254 payments
- Organon LLCProgram year20258 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
29.9%Azole Antifungal15.9%Ketoconazole100%Part D≥260 patientsTetracycline-class Drug3.9%Doxycycline Hyclate100%Part D≥92 patients+ 5 more classes in this area
Respiratory
25.9%Corticosteroid14.2%Mometasone Furoate100%Part D≥252 patientsRNA Synthetase Inhibitor Antibacterial11.6%Mupirocin100%Part D≥243 patientsSensory organs
24%Corticosteroid22.1%Hydrocortisone53%Clobetasol Propionate35%Betamethasone Dipropionate6%Desonide6%Part D≥228 patientsAminoglycoside Antibacterial1.9%Gentamicin Sulfate100%Part D≥47 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Critical Considerations on Optimizing Topical Corticosteroid Therapy
PubMed Central
2015 - [Not Available].
PubMed
2015
Most-cited works
by citation count (OpenAlex)- 01
- 02Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery.Article60 citations2008
- 03The significance of tumor persistence after incomplete excision of basal cell carcinomaArticle59 citations2002
- 04
- 05
Online presence
Updated 4 Nov 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/joshua-berlin-md
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/p/Premier-Dermatology-Partners-Joshua-Berlin-MD-100089606782613
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Other
berlindermatology.com/providers/joshua-m-berlin-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →berlindermatology.com ↗ - Other
healthgrades.com/physician/dr-joshua-berlin-xcnl7
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗ - Other
nursing.upenn.edu/live/profiles/19616-dr-joshua-berlin
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nursing.upenn.edu ↗ - Other
solvhealth.com/provider/joshua-berlin-GOOmVG
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →solvhealth.com ↗ - Other
topdermatology.com/joshua-berlin-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →topdermatology.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 4 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →topdermatology.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Robert Modlin, MD
University of California, Los Angeles
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Joel Gelfand, MD
University of Pennsylvania